arrow
J

Johannes Gollmer

Medical University of Graz
H指数:9
被引数:295

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Erythrocyte and Platelet Indices at Admission and Discharge Stratify Long-Term Cardiovascular Risk After Invasive Treatment of Myocardial Infarction

入院和出院时的红细胞和血小板指数可分层心肌梗死侵入性治疗后长期心血管风险

2026-06-090
OA
Simultaneous transcatheter edge-to-edge repair (TEER) for severe mitral and tricuspid regurgitation is feasible, safe, and associated with good clinical outcome

经导管缘对缘修复(TEER)同时治疗严重二尖瓣和三尖瓣反流是可行的、安全的,并且与良好的临床结局相关

2026-02-100
PRE
Impact of Ertugliflozin on Cardiac Structure and Function in Patients with ICDs/CRT-Ds Assessed by Echocardiography: A Post Hoc Sub-Analysis of the ERASe Trial

Ertugliflozin对植入ICD/CRT-D患者心脏结构与功能的影响:基于ERASe试验的事后亚组分析

2025-11-220
OAAI
Cardiomyocyte-Specific Deletion of Sirtuin 5 Accelerates the Development of Heart Failure Upon Dysregulating Purine Metabolism

Sirtuin 5心肌细胞特异性敲除通过调控嘌呤代谢加速心力衰竭的发展

2025-10-170
OAAI
Applying DanGer Shock Eligibility Criteria to a Real-World Cohort of Cardiogenic Shock Patients

将DanGer Shock资格标准应用于真实世界中 cardiogenic shock 患者队列

2025-10-010
OAAI
Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trial

通过超声心动图评估empagliflozin对心肌梗死后心脏结构和功能的影响: emmy试验的事后子分析

2024-09-160
OAAI
Low-grade systemic inflammation and left ventricular dysfunction in hypertensive compared to non-hypertensive hypertrophic cardiomyopathy

与非高血压肥厚型心肌病相比,高血压患者的低度全身性炎症和左心功能不全

2024-03-012
OAAI